[Senolytics against Covid-19?] / Les sénolytiques contre la Covid-19 ? - Chroniques génomiques.
Med Sci (Paris)
; 37(11): 1062-1065, 2021 Nov.
Article
in French
| MEDLINE | ID: covidwho-1545680
ABSTRACT
The elimination of some senescent cells by « senolytic ¼ compounds can greatly improve the health of aged mice and in some cases reverse the effects of aging. Using a microbial exposure system that closely models coronavirus infection, it is possible to largely protect old mice from the effects of viral infection. This immediately suggests clinical application of the approach, and is the aim of ongoing phase II clinical trials in Covid-19 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cellular Senescence
/
Senotherapeutics
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Animals
/
Humans
Language:
French
Journal:
Med Sci (Paris)
Journal subject:
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Medsci
Similar
MEDLINE
...
LILACS
LIS